Skip to content
Home/Companies/Biotech/Advanced BioDesign
Advanced BioDesign

Advanced BioDesign

Biotech·France·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns Advanced BioDesign?

Advanced BioDesign is a French Biotech company, currently owned by Xerys Invest since 2016.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Xerys Invest
Investor
Xerys Invest
Xerys Capital France · 2014 · Growth

Key facts

HQFrance
SectorBiotech
Websitea-biodesign.com

More from Xerys Capital France

Other portfolio companies in the same fund.

Biolog-id
Biolog-id
Active
MedTechFrance· 2022
PowiDian Mobility / LMI
Active
France· 2021
Optionizr
Optionizr
Exited 2025
TMTFrance· 2018
to SoftNext
7Hugs Labs
Exited 2020
SoftwareFrance· 2017
to Qorvo
AlzProtect
AlzProtect
Active
BiotechFrance· 2017
Powidian
Active
ClimateTechFrance· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Advanced BioDesign?

Advanced BioDesign is currently owned by Xerys Invest, through Xerys Capital France, since 2016.

When did Xerys Invest acquire Advanced BioDesign?

Xerys Invest acquired Advanced BioDesign in 2016.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue